Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-16

Clinical Trial Update: Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating low-dose ketamine after gastric bypass and gastrectomy completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: NYU Langone Health | Conditions: Pain, Postoperative Depression | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-03-16